Li QV, Dixon G, Verma N, Rosen BP, Gordillo M, Luo R, Xu C, Wang Q, Soh C-L, Yang D et al..  2019.  Genome-scale screens identify JNK-JUN signaling as a barrier for pluripotency exit and endoderm differentiation.. Nat Genet. 51(6):999-1010.

Pulecio J, Verma N, Mejía-Ramírez E, Huangfu D, Raya A.  2017.  CRISPR/Cas9-Based Engineering of the Epigenome.. Cell Stem Cell. 21(4):431-447.

Sacta MA, Chinenov Y, Rogatsky I.  2016.  Glucocorticoid Signaling: An Update from a Genomic Perspective.. Annu Rev Physiol. 78:155-80.

Dow LE, Fisher J, O'Rourke KP, Muley A, Kastenhuber ER, Livshits G, Tschaharganeh DF, Socci ND, Lowe SW.  2015.  Inducible in vivo genome editing with CRISPR-Cas9.. Nat Biotechnol. 33(4):390-394.

Ouyang J, Garner E, Hallet A, Nguyen HDang, Rickman KA, Gill G, Smogorzewska A, Zou L.  2015.  Noncovalent interactions with SUMO and ubiquitin orchestrate distinct functions of the SLX4 complex in genome maintenance.. Mol Cell. 57(1):108-22.

González F, Zhu Z, Shi Z-D, Lelli K, Verma N, Li QV, Huangfu D.  2014.  An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells.. Cell Stem Cell. 15(2):215-226.

Martin DL, D Weatherly B, Laucella SA, Cabinian MA, Crim MT, Sullivan S, Heiges M, Craven SH, Rosenberg CS, Collins MH et al..  2006.  CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes.. PLoS Pathog. 2(8):e77.